Skip Navigation LinksHome > May 2007 - Volume 13 - Issue 5 > Growth retardation in pediatric Crohn's disease: Pathogenesi...
Inflammatory Bowel Diseases:
doi: 10.1002/ibd.20115
Pediatric Review: Growth Retardation in Pediatric CD: Pediatric Review

Growth retardation in pediatric Crohn's disease: Pathogenesis and interventions

Shamir, Raanan MD1,4; Phillip, Moshe MD2,5; Levine, Arie MD3,5*

Collapse Box

Abstract

Abstract: Growth retardation (GR) may pose a significant challenge to the quality of life and the proper management of children and adolescents with Crohn's disease (CD). It can occur in a significant proportion of patients, and may precede clinical evidence of bowel disease. Current evidence suggests that GR is a complex interaction between nutritional status, inflammation, disease severity, and genotype, which causes resistance to the effects of growth hormone. Recent research has identified a key role for the inflammatory cytokines TNF alpha, IL‐6, and IL1 beta. This review summarizes current knowledge as well as gaps in our understanding of the mechanisms involved and the usefulness of the different treatment modalities in promoting growth in CD patients.

(Inflamm Bowel Dis 2007)

© Crohn's & Colitis Foundation of America, Inc.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.